Will Rogers FellowDr. Hunt
Study: Cystic Fibrosis
The life expectancy of someone with CF 20 to 30 years ago was 18 years old. Innovative advances in Cystic Fibrosis research have increased that same person’s life expectancy to his or her 40s, 50s and even 60s.
Dr. Hunt’s interest in CF began during his pulmonary rotation in Pediatrics and Internal Medicine. He was introduced to many young children suffering from CF and quickly learned that it is a very isolating disease. There are no special camps for patients with CF - the potential to become sicker is not worth the risk. He also noticed that as patients with CF live longer, they have to learn to deal with adult issues – a relatively new problem.
Currently about half of all adult CF patients will develop a special type of diabetes. The diagnosis of diabetes makes CF difficult to manage and the prognosis is much worse.
Dr. Hunt’s focus is to provide outstanding care to adults with CF but also develop better therapies to deal with the difficulties of adult Cystic Fibrosis.
Emory’s mission is to become on of the top five Pulmonary & Critical Care Programs in the country with outstanding programs in teaching, patient care, and research.
One of the unique aspects of their training program is that it individualizes the second- and third- year experience for each trainee to target their career goals. The flexibility of the Will Rogers fellowship gives the scientist-clinician the ability to train and succeed in the field that best suits him or her. Emory has doubled the size of fellows with the help of funding from the Will Rogers Institute.
In 2013, Emory University was selected as one of four programs to receive the Innovation in Fellowship Education Award from the American Thoracic Society. The award values the importance of a solid and reputable fellowship training program.
Dr. Guidot received the WRI fellowship in 1990 while attending Colorado. He is also director of the Alcohol and Lung Biology Center. His clinical interests include the care of critically ill patients with acute lung injury, and the diagnosis and management of airway diseases including asthma, emphysema, and chronic bronchitis. One of his greatest contributions is in the research laboratory where he has trained more than a dozen fellows and residents in pulmonary medicine.
Dr. Schulman serves as Associate Division Director for Education and has taken an active role in fellow training, winning several awards. His clinical and has directed the Sleep Program and focuses on long-term repercussions of sleep-disordered berthing.